Metraipolis › archive › dc_ce25da8041ef

Efficacy and safety of labetalol vs. Hydralazine in pregnant women with severe hypertension — Europe PMC PMID:41737174

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41737174
DOI: 10.12669/pjms.42.1.12247
License (as archived): solo-consultazione
Archived: 2026-11-07T05:03:31.456Z
SHA-256 of the archived text: 4249c7cd00ab9a430c1d9778f75c91fa2078408309567f3ee9616f01977364a5
Stable URL of this page: https://metraipolis.com/documento/dc_ce25da8041ef

How to cite

Efficacy and safety of labetalol vs. Hydralazine in pregnant women with severe hypertension — Europe PMC PMID:41737174 — Europe PMC (en), https://europepmc.org/article/MED/41737174 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce25da8041ef (Metraipolis archive dc_ce25da8041ef, sha256 4249c7cd00ab9a430c1d9778f75c91fa2078408309567f3ee9616f01977364a5)

BibTeX

@misc{dcce25da8041ef,
  title = {Efficacy and safety of labetalol vs. Hydralazine in pregnant women with severe hypertension — Europe PMC PMID:41737174},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41737174},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce25da8041ef; sha256 4249c7cd00ab9a430c1d9778f75c91fa2078408309567f3ee9616f01977364a5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41737174. Agents can read the archived copy with the MCP tool read_document.